Osteoarthritis: assessment for use of anti-inflammatory or analgesic over-the-counter (OTC) medications (NQF 0051)

EMeasure Name Osteoarthritis: assessment for use of anti-inflammatory or analgesic over-the-counter (OTC) medications EMeasure Id D4D47CF4-016B-462A-BA6A-14D581E073A8
Version number 1 Set Id F6E5D296-9DC9-4623-B18F-DE3B801176DD
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward American Medical Association - Physician Consortium for Performance Improvement
Endorsed by National Quality Forum
Description Percentage of patient visits for patients aged 21 years and older with a diagnosis of OA with an assessment for use of anti-inflammatory or analgesic OTC medications
Copyright
© 2010 American Medical Association. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
Treatment goals for OA are to reduce pain, maintain or improve joint mobility, and limit functional impairment. Use of anti-inflammatory and analgesics has a documented role in these goals. Assessment of current medication use is a precursor to appropriate pharmacologic therapy.
Clinical Recommendation Statement
Although it is one of the safest analgesics, acetaminophen can be associated with clinically important adverse events. Recent reports have highlighted long-recognized conditions in which increased awareness of potential toxicity is important. (American College of Rheumatology, 2000). Additional considerations involved in a practitioner’s decision to treat the individual OA patient include existing comorbidities and concomitant therapy, as well as the side effects and costs of specific treatments. (American College of Rheumatology, 2000)
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee. 2000 Update. Arthritis Rheum. Sept 2000;43: 1905-1915.
Definition
Assessment may include: Documentation of current medications, continue same medications, change in medication dose, documentation indicating that the patient was asked about OTC medication use
Guidance
In the initial patient population, for the "encounter" QDS element, note that two or more visits are required during the measurement year for the patient to be included in the measure; if the patient in only seen once by the eligible professional, the patient is not included in the measure.  A diagnosis of osteoarthritis should be present prior to or  during any of the visits during the measurement year.

Medication reconciliation guidance: Medication reconciliation is expected to reconcile all medications, both prescription and over-the-counter, on the medication list for interaction.

Table of Contents


Population criteria

Data criteria (QDS Data Elements)

Summary Calculation

Calculation is generic to all measures:



Measure set CLINICAL QUALITY MEASURE SET 2011-2012